Operaciones Medtronic - MDT CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.17 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024068% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.001846% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Medtronic PLC ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Estadísticas clave
| Cierre previo* | 81.13 |
| Abrir* | 81.13 |
| Cambio de 1 año* | -25.21% |
| Rango del día* | 81.02 - 81.68 |
| Rango de 52 semanas | 75.77-114.31 |
| Volumen medio (10 días) | 6.68M |
| Volumen medio (3 meses) | 129.53M |
| Capitalización de mercado | 105.92B |
| Ratio P/E | 26.17 |
| Acciones en circulación | 1.33B |
| Ingresos | 30.77B |
| EPS | 3.04 |
| Dividendo (Rendimiento %) | 3.41666 |
| Beta | 0.73 |
| Próxima fecha de resultados | May 25, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Mar 21, 2023 | 81.13 | 1.23 | 1.54% | 79.90 | 81.33 | 79.43 |
| Mar 20, 2023 | 79.49 | 0.90 | 1.15% | 78.59 | 79.70 | 78.25 |
| Mar 17, 2023 | 78.12 | -1.09 | -1.38% | 79.21 | 79.29 | 77.72 |
| Mar 16, 2023 | 79.20 | 2.02 | 2.62% | 77.18 | 79.33 | 77.04 |
| Mar 15, 2023 | 78.31 | 1.77 | 2.31% | 76.54 | 78.31 | 76.54 |
| Mar 14, 2023 | 77.73 | -1.32 | -1.67% | 79.05 | 79.25 | 76.95 |
| Mar 13, 2023 | 77.92 | 1.97 | 2.59% | 75.95 | 78.41 | 75.93 |
| Mar 10, 2023 | 76.62 | -1.10 | -1.42% | 77.72 | 78.02 | 76.02 |
| Mar 9, 2023 | 77.90 | -0.41 | -0.52% | 78.31 | 79.25 | 77.88 |
| Mar 8, 2023 | 78.30 | -1.16 | -1.46% | 79.46 | 79.51 | 77.93 |
| Mar 7, 2023 | 79.71 | -2.23 | -2.72% | 81.94 | 82.00 | 79.38 |
| Mar 6, 2023 | 81.83 | -1.49 | -1.79% | 83.32 | 83.74 | 81.34 |
| Mar 3, 2023 | 83.33 | 1.28 | 1.56% | 82.05 | 83.52 | 82.05 |
| Mar 2, 2023 | 82.13 | 0.75 | 0.92% | 81.38 | 82.49 | 81.07 |
| Mar 1, 2023 | 81.96 | -0.03 | -0.04% | 81.99 | 82.45 | 81.56 |
| Feb 28, 2023 | 82.70 | -0.43 | -0.52% | 83.13 | 83.61 | 82.45 |
| Feb 27, 2023 | 83.27 | 0.07 | 0.08% | 83.20 | 84.04 | 82.97 |
| Feb 24, 2023 | 83.40 | 0.61 | 0.74% | 82.79 | 83.59 | 82.10 |
| Feb 23, 2023 | 83.89 | -0.75 | -0.89% | 84.64 | 84.99 | 83.31 |
| Feb 22, 2023 | 85.01 | -0.87 | -1.01% | 85.88 | 86.29 | 84.62 |
Medtronic Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| No events scheduled | ||
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 31686 | 30117 | 28913 | 30557 | 29953 |
| Ingresos | 31686 | 30117 | 28913 | 30557 | 29953 |
| Coste de los ingresos, total | 9971 | 10355 | 9269 | 9064 | 9039 |
| Beneficio bruto | 21715 | 19762 | 19644 | 21493 | 20914 |
| Gastos totales de explotación | 25934 | 25941 | 24535 | 24774 | 23351 |
| Gastos de venta/general/administración Gastos, total | 10135 | 9776 | 9875 | 10232 | 9953 |
| Investigación y desarrollo | 2746 | 2493 | 2331 | 2330 | 2256 |
| Depreciation / Amortization | 1733 | 1783 | 1756 | 1764 | 1823 |
| Gasto (ingreso) por intereses - Explotación neta | -117 | -224 | 226 | ||
| Gastos (ingresos) extraordinarios | 1154 | 1219 | 1303 | 1342 | -172 |
| Other Operating Expenses, Total | 195 | 315 | 118 | 266 | 226 |
| Ingresos de explotación | 5752 | 4176 | 4378 | 5783 | 6602 |
| Ingresos por intereses (gastos), netos No operativos | -541 | -425 | -379 | -676 | -938 |
| Otros, netos | 306 | 144 | 56 | 90 | 11 |
| Ingresos netos antes de impuestos | 5517 | 3895 | 4055 | 5197 | 5675 |
| Ingresos netos después de impuestos | 5061 | 3524 | 4743 | 4662 | 5377 |
| Intereses menores | -22 | -24 | -17 | -19 | 9 |
| Beneficio neto antes de partidas extra. Elementos | 5039 | 3500 | 4726 | 4643 | 5386 |
| Ingresos netos | 5039 | 3606 | 4789 | 4631 | 3104 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 5039 | 3500 | 4726 | 4643 | 5386 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 5039 | 3606 | 4789 | 4631 | 3104 |
| Beneficio neto diluido | 5039 | 3606 | 4789 | 4631 | 3104 |
| Promedio ponderado de acciones diluidas | 1351.4 | 1354 | 1351.1 | 1357.5 | 1368.2 |
| BPA diluido sin partidas extraordinarias | 3.72873 | 2.58493 | 3.49789 | 3.42026 | 3.93656 |
| Dividends per Share - Common Stock Primary Issue | 2.52 | 2.32 | 2.16 | 2 | 1.84 |
| BPA normalizado diluido | 4.58931 | 3.55835 | 4.13123 | 4.31147 | 3.82352 |
| Total de partidas extraordinarias | 106 | 63 | -12 | -2282 | |
| Total Adjustments to Net Income | 0 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Ingresos totales | 8089 | 7763 | 7847 | 7987 | 8188 |
| Ingresos | 8089 | 7763 | 7847 | 7987 | 8188 |
| Coste de los ingresos, total | 2565 | 2433 | 2466 | 2507 | 2620 |
| Beneficio bruto | 5524 | 5330 | 5381 | 5480 | 5568 |
| Gastos totales de explotación | 6418 | 6104 | 6284 | 7128 | 6583 |
| Gastos de venta/general/administración Gastos, total | 2570 | 2521 | 2579 | 2510 | 2348 |
| Investigación y desarrollo | 652 | 668 | 676 | 750 | 632 |
| Depreciation / Amortization | 435 | 432 | 431 | 436 | 446 |
| Gastos (ingresos) extraordinarios | 53 | 113 | 111 | 833 | 338 |
| Other Operating Expenses, Total | 143 | -63 | 21 | 92 | 199 |
| Ingresos de explotación | 1671 | 1659 | 1563 | 859 | 1605 |
| Ingresos por intereses (gastos), netos No operativos | -167 | -103 | -86 | -51 | -94 |
| Otros, netos | 98 | 33 | 16 | 25 | 55 |
| Ingresos netos antes de impuestos | 1602 | 1589 | 1493 | 833 | 1566 |
| Ingresos netos después de impuestos | 1492 | 1483 | 1317 | 769 | 1366 |
| Intereses menores | -6 | -4 | -6 | -6 | -6 |
| Beneficio neto antes de partidas extra. Elementos | 1486 | 1479 | 1311 | 763 | 1360 |
| Ingresos netos | 1486 | 1479 | 1311 | 763 | 1360 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 1485 | 1480 | 1311 | 763 | 1360 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 1485 | 1480 | 1311 | 763 | 1360 |
| Beneficio neto diluido | 1485 | 1480 | 1311 | 763 | 1360 |
| Promedio ponderado de acciones diluidas | 1343.9 | 1350.3 | 1355.3 | 1344.5 | 1357.9 |
| BPA diluido sin partidas extraordinarias | 1.10499 | 1.09605 | 0.96731 | 0.5675 | 1.00155 |
| Dividends per Share - Common Stock Primary Issue | 0.63 | 0.63 | 0.63 | 0.63 | 0.58 |
| BPA normalizado diluido | 1.05737 | 1.11753 | 1.06914 | 1.32317 | 1.38596 |
| Total Adjustments to Net Income | -1 | 1 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 23059 | 22548 | 22031 | 21967 | 22980 |
| Efectivo e inversiones a corto plazo | 10573 | 10817 | 10948 | 9848 | 11227 |
| Efectivo y Equivalentes | 3714 | 3593 | 4140 | 4393 | 3669 |
| Inversiones a corto plazo | 6859 | 7224 | 6808 | 5455 | 7558 |
| Total deudores, neto | 5551 | 5462 | 4645 | 6222 | 5987 |
| Accounts Receivable - Trade, Net | 5551 | 5462 | 4645 | 6222 | 5987 |
| Total Inventory | 4616 | 4313 | 4229 | 3753 | 3579 |
| Other Current Assets, Total | 2319 | 1956 | 2209 | 2144 | 2187 |
| Total Assets | 90981 | 93083 | 90689 | 89694 | 91393 |
| Property/Plant/Equipment, Total - Net | 6267 | 6219 | 5755 | 4675 | 4604 |
| Property/Plant/Equipment, Total - Gross | 14219 | 13698 | 12571 | 10920 | 10259 |
| Accumulated Depreciation, Total | -7952 | -7479 | -6816 | -6245 | -5655 |
| Goodwill, Net | 40502 | 41961 | 39841 | 39959 | 39543 |
| Intangibles, Net | 15595 | 17740 | 19063 | 20560 | 21723 |
| Long Term Investments | 881 | 687 | 480 | 372 | 515 |
| Other Long Term Assets, Total | 4677 | 3928 | 3519 | 2161 | 2028 |
| Total Current Liabilities | 12394 | 8509 | 10366 | 8472 | 10084 |
| Accounts Payable | 2276 | 2106 | 1996 | 1953 | 1628 |
| Accrued Expenses | 5367 | 5681 | 4839 | 4885 | 5232 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 3742 | 11 | 2776 | 838 | 2058 |
| Other Current Liabilities, Total | 1009 | 711 | 755 | 796 | 1166 |
| Total Liabilities | 38430 | 41655 | 39952 | 39603 | 40673 |
| Total Long Term Debt | 20372 | 26378 | 22021 | 24486 | 23699 |
| Long Term Debt | 20316 | 26316 | 21976 | 24476 | 23678 |
| Capital Lease Obligations | 56 | 62 | 45 | 10 | 21 |
| Deferred Income Tax | 884 | 1028 | 1174 | 1278 | 1423 |
| Minority Interest | 171 | 174 | 135 | 121 | 102 |
| Other Liabilities, Total | 4609 | 5566 | 6256 | 5246 | 5365 |
| Total Equity | 52551 | 51428 | 50737 | 50091 | 50720 |
| Common Stock | 0.13307 | 0.13454 | 0.13411 | 0.13407 | 0 |
| Additional Paid-In Capital | 24566 | 26319 | 26165 | 26532 | 28127 |
| Retained Earnings (Accumulated Deficit) | 30250 | 28594 | 28132 | 26270 | 24379 |
| Unrealized Gain (Loss) | -209 | 92 | 0 | -45 | -194 |
| Other Equity, Total | -2056.13 | -3577.13 | -3560.13 | -2666.13 | -1592 |
| Total Liabilities & Shareholders’ Equity | 90981 | 93083 | 90689 | 89694 | 91393 |
| Total Common Shares Outstanding | 1330.74 | 1345.4 | 1341.07 | 1340.7 | 1354.22 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 23059 | 23303 | 22731 | 22434 | 22548 |
| Efectivo e inversiones a corto plazo | 10573 | 11221 | 10669 | 10595 | 10817 |
| Efectivo y Equivalentes | 3714 | 3479 | 2900 | 3004 | 3593 |
| Inversiones a corto plazo | 6859 | 7742 | 7769 | 7591 | 7224 |
| Total deudores, neto | 5551 | 5446 | 5493 | 5431 | 5462 |
| Accounts Receivable - Trade, Net | 5551 | 5446 | 5493 | 5431 | 5462 |
| Total Inventory | 4616 | 4514 | 4349 | 4288 | 4313 |
| Other Current Assets, Total | 2319 | 2122 | 2220 | 2120 | 1956 |
| Total Assets | 90981 | 91804 | 91756 | 91802 | 93083 |
| Property/Plant/Equipment, Total - Net | 5413 | 5251 | 5188 | 5162 | 6219 |
| Property/Plant/Equipment, Total - Gross | 13365 | 13074 | 12978 | 12808 | 12700 |
| Accumulated Depreciation, Total | -7952 | -7823 | -7790 | -7646 | -7479 |
| Goodwill, Net | 40502 | 41346 | 41612 | 41720 | 41961 |
| Intangibles, Net | 15595 | 16078 | 16523 | 16890 | 17740 |
| Long Term Investments | 881 | 827 | 781 | 692 | 687 |
| Other Long Term Assets, Total | 5531 | 4999 | 4921 | 4904 | 3928 |
| Total Current Liabilities | 12394 | 8927 | 7803 | 7764 | 8509 |
| Accounts Payable | 2276 | 1985 | 1917 | 1864 | 2106 |
| Accrued Expenses | 5672 | 5694 | 5403 | 5553 | 5681 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 3742 | 865 | 16 | 6 | 11 |
| Other Current Liabilities, Total | 704 | 383 | 467 | 341 | 711 |
| Total Liabilities | 38430 | 39262 | 39765 | 40316 | 41655 |
| Total Long Term Debt | 20372 | 24290 | 25607 | 25958 | 26378 |
| Long Term Debt | 20316 | 24232 | 25548 | 25898 | 26316 |
| Capital Lease Obligations | 56 | 58 | 59 | 60 | 62 |
| Deferred Income Tax | 884 | 968 | 1024 | 1054 | 1028 |
| Minority Interest | 171 | 171 | 168 | 178 | 174 |
| Other Liabilities, Total | 4609 | 4906 | 5163 | 5362 | 5566 |
| Total Equity | 52551 | 52542 | 51991 | 51486 | 51428 |
| Common Stock | 0.13307 | 0.13426 | 0.13449 | 0.13447 | 0.13454 |
| Additional Paid-In Capital | 24566 | 25814 | 26059 | 26184 | 26319 |
| Retained Earnings (Accumulated Deficit) | 30250 | 29607 | 28974 | 28511 | 28594 |
| Unrealized Gain (Loss) | -209 | -22 | 48 | 104 | 92 |
| Other Equity, Total | -2056.13 | -2857.13 | -3090.13 | -3313.13 | -3577.13 |
| Total Liabilities & Shareholders’ Equity | 90981 | 91804 | 91756 | 91802 | 93083 |
| Total Common Shares Outstanding | 1330.74 | 1342.57 | 1344.86 | 1344.67 | 1345.4 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | 5062 | 3630 | 4806 | 4650 | 3095 |
| Efectivo de actividades de explotación | 7347 | 6240 | 7234 | 7007 | 4684 |
| Efectivo de actividades de explotación | 2707 | 2702 | 2663 | 2659 | 2644 |
| Deferred Taxes | -604 | -422 | -1315 | -304 | -919 |
| Partidas no monetarias | 1070 | 1031 | 1019 | 1082 | 37 |
| Cash Taxes Paid | 996 | 1250 | 878 | 1558 | 2542 |
| Intereses pagados en efectivo | 540 | 582 | 643 | 973 | 1147 |
| Cambios en el capital circulante | -888 | -701 | 61 | -1080 | -173 |
| Efectivo de actividades de inversión | -1659 | -2866 | -3203 | -774 | 5858 |
| Gastos de capital | -1368 | -1355 | -1213 | -1134 | -1068 |
| Otras partidas de flujo de caja de inversión, total | -291 | -1511 | -1990 | 360 | 6926 |
| Efectivo procedente de actividades de financiación | -5336 | -4136 | -4198 | -5431 | -11954 |
| Elementos de flujo de caja de financiación | 163 | -268 | -81 | 14 | -50 |
| Total Cash Dividends Paid | -3383 | -3120 | -2894 | -2693 | -2494 |
| Emisión (retiro) de acciones, neto | -2115 | -178 | -664 | -1885 | -1768 |
| Emisión (amortización) de deuda, neta | -1 | -570 | -559 | -867 | -7642 |
| Efectos del cambio de divisas | -231 | 215 | -86 | -78 | 114 |
| Variación neta de la tesorería | 121 | -547 | -253 | 724 | -1298 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 5062 | 3570 | 2086 | 769 | 3630 |
| Cash From Operating Activities | 7347 | 5289 | 3061 | 1292 | 6240 |
| Cash From Operating Activities | 2707 | 2019 | 1347 | 671 | 2702 |
| Deferred Taxes | -604 | -234 | -78 | -11 | -422 |
| Non-Cash Items | 1070 | 943 | 888 | 715 | 1031 |
| Cash Taxes Paid | 996 | 842 | 615 | 249 | 1250 |
| Cash Interest Paid | 540 | 295 | 280 | 63 | 582 |
| Changes in Working Capital | -888 | -1009 | -1182 | -852 | -701 |
| Cash From Investing Activities | -1659 | -1930 | -1493 | -784 | -2866 |
| Capital Expenditures | -1368 | -979 | -649 | -378 | -1355 |
| Other Investing Cash Flow Items, Total | -291 | -951 | -844 | -406 | -1511 |
| Cash From Financing Activities | -5336 | -3387 | -2210 | -1055 | -4136 |
| Financing Cash Flow Items | 163 | -52 | -46 | -4 | -268 |
| Total Cash Dividends Paid | -3383 | -2540 | -1693 | -846 | -3120 |
| Issuance (Retirement) of Stock, Net | -2115 | -794 | -470 | -204 | -178 |
| Issuance (Retirement) of Debt, Net | -1 | -1 | -1 | -1 | -570 |
| Foreign Exchange Effects | -231 | -87 | -51 | -42 | 215 |
| Net Change in Cash | 121 | -115 | -693 | -589 | -547 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.3573 | 124491788 | 1243126 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.4559 | 72586912 | 3184703 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.512 | 60029051 | 1039338 | 2022-12-31 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 2.548 | 33898890 | 1194858 | 2022-12-31 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.2442 | 29857047 | -1240263 | 2022-12-31 | LOW |
| Capital Research Global Investors | Investment Advisor | 2.1658 | 28814669 | 37199 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.0461 | 27222300 | 423715 | 2022-12-31 | LOW |
| BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.2071 | 16059161 | 936343 | 2022-12-31 | LOW |
| Managed Account Advisors LLC | Investment Advisor | 1.0987 | 14617260 | -3767415 | 2022-12-31 | LOW |
| JP Morgan Asset Management | Investment Advisor | 1.0919 | 14527410 | -214609 | 2022-12-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0274 | 13668496 | 626225 | 2022-12-31 | LOW |
| DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.9969 | 13263284 | 1797223 | 2022-12-31 | LOW |
| Sanders Capital, LLC | Investment Advisor | 0.9515 | 12658542 | -199168 | 2022-12-31 | LOW |
| American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.9013 | 11990457 | 545538 | 2022-12-31 | LOW |
| Wells Fargo Advisors | Research Firm | 0.8866 | 11794893 | -258903 | 2022-12-31 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7999 | 10641725 | 2548341 | 2022-12-31 | LOW |
| Invesco Advisers, Inc. | Investment Advisor | 0.7763 | 10328189 | 1336047 | 2022-12-31 | LOW |
| AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 0.7543 | 10034945 | 194817 | 2022-12-31 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7234 | 9624338 | -453649 | 2022-12-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.7002 | 9315796 | 255281 | 2022-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Medtronic Company profile
Sobre Medtronic PLC
MEDTRONIC PUBLIC LIMITED COMPANY es una compañía de tecnología y servicios médicos. La Compañía desarrolla, fabrica y comercializa sus dispositivos y tecnologías médicas a hospitales, doctores, médicos clínicos y pacientes en aproximadamente 160 países. La Compañía opera en cuatro segmentos: Grupo Cardíaco y Vascular, Grupo de Tecnologías Mínimamente Invasivas, Grupo de Terapias Restaurativas, y el Grupo de Diabetes. El segmento Grupo Cardíaco y Vascular incluye Ritmo Cardíaco e Insuficiencia Cardíaca, Coronaria y Estructura de Corazón y Vascular Periférica y Aórtica. Su segmento Grupo de Tecnologías Mínimamente Invasivas incluye Soluciones Quirúrgicas y Seguimiento y Recuperación del Paciente. Su segmento Grupo de Terapias Restaurativas incluye Columna, Neuromodulación, Tecnologías Quirúrgicas y Neurovascular. Su segmento Grupo de Diabetes incluye Manejo Intensivo de Insulina, Terapias no Intensivas para Diabetes y Servicios y Soluciones para Diabetes. Las filiales de la Compañía incluyen Medtronic, Inc. y HeartWare International, Inc.
- IndustriaAdvanced Medical Equipment
- Dirección20 On Hatch, Hatch Street Lower, DUBLIN, Ireland (IRL)
- Empleados90000
- CEOGeoffrey Martha
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
20 On Hatch
Hatch Street Lower
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com